Page last updated: 2024-10-29

ketoconazole and Acquired Autoimmune Hemolytic Anemia

ketoconazole has been researched along with Acquired Autoimmune Hemolytic Anemia in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ogushi, F1
Tamura, M1
Ozaki, T1
Kamei, T1
Nakanishi, M1
Shimada, H1
Kawano, T1
Yasuoka, S1
Tsubura, E1

Other Studies

1 other study available for ketoconazole and Acquired Autoimmune Hemolytic Anemia

ArticleYear
[A case of cryptococcal meningitis improved in the treatment of high dose ketoconazole].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1985, Volume: 59, Issue:4

    Topics: Anemia, Hemolytic, Autoimmune; Cryptococcosis; Female; Humans; Ketoconazole; Lupus Erythematosus, Sy

1985